Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Soil Microbes Yield Rich Antibiotic Sources

Researchers taking soil samples

A group of geo- and bioscience researchers analyzed microbes residing in soil under northern California and discovered many new potential sources of antibiotics, well beyond current sources. . . . → Read More: Soil Microbes Yield Rich Antibiotic Sources

Natural, Engineered Microbes Shown to Control Cholera

Distributing water hygiene kits

A combination of natural bacteria found in milk products and a synthetic variation of those microbes are shown in tests with lab mice to detect and prevent cholera infections. . . . → Read More: Natural, Engineered Microbes Shown to Control Cholera

Hospital Network Formed for Childhood Cancer Immunotherapies

T-cells illustration

A network of academic children’s medical centers is being formed to expand access to clinical trials testing immunotherapy treatments for childhood cancer. . . . → Read More: Hospital Network Formed for Childhood Cancer Immunotherapies

FDA Issues Guidance on Patient Experience Data Collection

Scott Gottlieb

The Food and Drug Administration issued draft regulatory guidance outlining methods for collecting data from patients that the agency says will help improve evaluations of more precisely targeted drugs. . . . → Read More: FDA Issues Guidance on Patient Experience Data Collection

$850M Deal Kicks Off RNA Vaccine Research

RNA strand illustration

Drug maker Sanofi is partnering with biotechnology company Translate Bio to develop vaccines against infectious diseases from messenger RNA, material transcribed from genetic codes in DNA. . . . → Read More: $850M Deal Kicks Off RNA Vaccine Research

NIH, Biotech Partner on Electro-Aided Crispr for Sickle Cell

Sickle cell illustration

The National Heart, Lung, and Blood Institute and a biotechnology company are testing genome editing with electronically treated cells as a therapy for sickle cell disease. . . . → Read More: NIH, Biotech Partner on Electro-Aided Crispr for Sickle Cell

Single Technology Produces Vaccines for Multiple Infectious Diseases

Ebola diagnostics

A single technology platform is being used to design and produce vaccines that in tests with lab animals protect against a number of infectious diseases. . . . → Read More: Single Technology Produces Vaccines for Multiple Infectious Diseases

Bacterial Genome Recoded to Produce Stable Protein Drugs

E. coli bacteria

A biotechnology lab devised techniques for genetically engineered bacteria to produce synthetic proteins that can last longer and are more stable than current protein production methods. . . . → Read More: Bacterial Genome Recoded to Produce Stable Protein Drugs

Stem Cell Transplants Found Safe for Spinal Cord Injuries

Spine model

Results from a clinical trial testing transplants of neural stem cells for spinal cord injuries show the therapies are safe for patients, with signs of improvement in most participants 1 to 2 years after treatment. . . . → Read More: Stem Cell Transplants Found Safe for Spinal Cord Injuries

Data Tools Designed for Genomics-Based Precision Cancer Care

Computational biology illustration

A computerized system is available that analyzes the genomic composition of cancer patients and recommends personalized treatments that its designers say take into account a larger array of factors than comparable systems. . . . → Read More: Data Tools Designed for Genomics-Based Precision Cancer Care